COMMUNIQUÉS West-GlobeNewswire

Sotera Health Announces Closing of $1.5 Billion Term Loan B and $750 Million Senior Secured Note Financings
30/05/2024
CLEVELAND, May 30, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and [...]
Noah Medical and CEO Dr. Jian Zhang Named Finalists in Surgical Robotics Technology (SRT) Industry Awards
30/05/2024
Next-generation robotics company and its CEO recognized separately for pioneering work, innovative new technology, and rapid progress SAN CARLOS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah [...]
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
30/05/2024
SOD1 -ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in Europe 1 QALSODY is Biogen’s third rare disease therapy to be approved in the EU, [...]
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
30/05/2024
GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies [...]
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
30/05/2024
Late-breaking presentation of data at American Transplant Congress on Monday, June 3 Data show potential to monitor for therapeutic efficacy and recurrence Potential repeat testing opportunities with claims expansion [...]
SAB Biotherapeutics Announces Departure of Chief Financial Officer
30/05/2024
MIAMI, May 30, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte [...]
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
30/05/2024
L eiden , the Netherlands, May 30, 2024 : Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today an update on the ongoing review of its Marketing Authorisation [...]
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
30/05/2024
Company will present promising preliminary progression-free survival and overall survival data for patients with combined positive score (CPS) ≥20 Conference call on Tuesday, June 4, at 4:15 p.m. ET NEW YORK and VIENNA [...]
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
30/05/2024
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical [...]
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
30/05/2024
NEW YORK and WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]
Dyadic to Attend Industry Events in June
30/05/2024
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in [...]
DBV Technologies to Participate in Upcoming EAACI 2024 Congress
30/05/2024
Châtillon, France, May 30, 2024 DBV Technologies to Participate in Upcoming EAACI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical [...]
DBV Technologies participera au prochain congrès EAACI 2024
30/05/2024
Châtillon, France, le 30 mai (22h30 CEST) 2024 DBV Technologies participera au prochain congrès EAACI 2024 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une société [...]
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
30/05/2024
ROCKVILLE, Md., May 30, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
CooperCompanies Announces Second Quarter 2024 Results
30/05/2024
SAN RAMON, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2024. Revenue [...]
Dentsply Sirona to Participate in Upcoming Investor Conferences
30/05/2024
CHARLOTTE, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. William Blair 44 th Annual Growth [...]
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
30/05/2024
FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 45 th [...]
Aura Biosciences to Participate in the Jefferies Global Healthcare Conference
30/05/2024
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the [...]
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
30/05/2024
Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digitial Insight solutions, and Myriad’s proprietary, FDA-approved MyChoice CDx® [...]

Pages